Cipher Pharmaceuticals Reports Q2 2018 Results

RXi Pharmaceuticals Reports First Quarter 2018 Financial Results and Recent Corporate Highlights.....»»

WALTHAM, Mass., May 11, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or the "Company"), a clinical-stage, specialty pharmaceutical company wi.....»»

Interim Analysis for Phase 3 HONOR study of Tonmya® .....»»

In the release issued under the same headline on May 10, 2018 by Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), please note that in the Consolidated Balance Sheets table, Cash and cash equi.....»»

NORTHVALE, N.J., June 14, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTC:ELTP), a specialty pharmaceutical co.....»»

Intercept Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Business Update.....»»

WALTHAM, Mass., Aug. 03, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or "the Company"), a clinical-stage, specialty pharmac.....»»

CONSHOHOCKEN, Pa., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Madrigal Pharma.....»»

ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2018 Results and Updates Guidance Acquires WellSpring Pharma Services for $18 Million in Cash to Expand Contract Manufacturing Business and Accelerate ANDA Pipeline .....»»

Portola Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update.....»»

Juniper Pharmaceuticals Reports Second Quarter 2018 Financial and Operati.....»»

NORTHVALE, N.J., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTC:ELTP), a specialty pharmaceutical company developing ab.....»»

Enrollment continues in Phase 3 GBM brain cancer trial Key European patent validated covering oral formulation of TSC Preparing for Phase 2 stroke trial with in-am.....»»

RXi Pharmaceuticals Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights.....»»

SAN DIEGO, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX), a clinical stage pharmaceutical company focused on the discovery, development a.....»»

InMed Pharmaceuticals Reports Fourth Quarter and Full Year Fiscal 2018 Financial Results and Provides R&D and Business Update.....»»

TORONTO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC:POLXF) (the "Company") today announced financial results for the second quarter of the 2019 fiscal year. The three-month and six-month periods ending July 31, 2018 (togeth.....»»

REDWOOD CITY, Calif., Nov. 2, 2018 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ:.....»»

DUBLIN, Ireland, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NA.....»»

-- Presented Updated Data from Phase 2 Basket Studies in Bardet-Biedl Syndrome (BBS) and Alström Syndrome at the 57th.....»»